Evidence map›Paper›PMID 38931863›Full record

ArticlePharmaceutics2024

Muna Rajab Elferjane, Violeta Milutinović, Milica Jovanović Krivokuća, Mohammad J Taherzadeh, Witold Pietrzak, Aleksandar Marinković, Aleksandra A Jovanović

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Modulation of Glycemic Control byFoods (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Plants (Basel, Switzerland) · 2025
    Article
  8. Phytochemical Characterisation ofPlants (Basel, Switzerland) · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muna Rajab ElferjaneFaculty of Nursing and Health Sciences, University of Misurata, Alshowahda Park, 3rd Ring Road, Misurata 2478, Libya.
Violeta MilutinovićFaculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia.
Milica Jovanović KrivokućaInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia.ORCID 0000-0001-8292-4853
Mohammad J TaherzadehSwedish Centre for Resource Recovery, University of Borås, Allégatan 61, 503 37 Borås, Sweden.ORCID 0000-0003-4887-2433
Witold PietrzakDepartment of Fermentation and Cereals Technology, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.
Aleksandar MarinkovićFaculty of Technology and Metallurgy, University of Belgrade, Karnegijeva 4, 11000 Belgrade, Serbia.
Aleksandra A JovanovićInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia.ORCID 0000-0001-5394-0125

Funding

COST Action FULLRECO4US, CA20133, supported by COST (European Cooperation in Science and Technology) CA20133
6 · The paper itself

Abstract

The aims of the present research include (1) optimization of extraction from

Indexed as

anti-inflammatory activityantioxidant activitybilberrycytotoxicityoptimizationpolyphenolic compoundswaste

Identifiers

PMID38931863
PMCPMC11206553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.